[HTML][HTML] SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider… - PLoS …, 2022 - journals.plos.org
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
KM Littlefield, RO Watson, JM Schneider, CP Neff… - Plos …, 2022 - europepmc.org
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
[HTML][HTML] SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider… - PLOS …, 2022 - journals.plos.org
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
KM Littlefield, RO Watson, JM Schneider… - PLoS …, 2022 - search.ebscohost.com
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider… - PLoS …, 2022 - pubmed.ncbi.nlm.nih.gov
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
KM Littlefield, RO Watson, JM Schneider, CP Neff… - 2022 - cabidigitallibrary.org
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
KM Littlefield, RO Watson, JM Schneider, CP Neff… - 2022 - agris.fao.org
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
[PDF][PDF] SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider, CP Neff… - PLoS …, 2022 - scienceopen.com
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
[PDF][PDF] SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider, CP Neff… - PLoS …, 2022 - researchgate.net
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
KM Littlefield, RO Watson, JM Schneider… - PLoS …, 2022 - search.proquest.com
As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …